EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSECRG00000002651
Gene Symbol: GUCY1A2
3 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSECRG00000022107
Gene Symbol: GUCY1B1
1 Cross references
210 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSECRG00000005308
Gene Symbol: GUCY1B1
3 Cross references
210 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSECRG00000020110
Gene Symbol: HSP90AA1
3 Cross references
266 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSECRG00000004131
Gene Symbol: HMGB1
3 Cross references
584 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSECRG00000019568
Gene Symbol: HRH1
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSECRG00000017096
Gene Symbol: HRH2A
1 Cross references
249 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSECRG00000016007
Gene Symbol: HDAC1
3 Cross references
308 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSECRG00000002810
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSECRG00000021200
Gene Symbol: HDAC11
3 Cross references
201 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSECRG00000004542
Gene Symbol: HDAC2
3 Cross references
205 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSECRG00000021111
Gene Symbol: HDAC4
3 Cross references
265 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).